Home» Circulars» Viewcirculars Back
 
Participation in CPhI-Tokyo, 22-24 April 2015 & BSM in Osaka on 20 April 2015
 

PxlHeaderLogo

Ref: PXL/H.O./CIR-094/2014-15                                              Date: 24.02.2015

OPPORTUNITY FOR ENTERING

JAPANESE MARKET (APIs/Generics/Neutraceuticals/Herbal extracts)/

CONTRACT MANUFACTURING

 

To
All the Members of Council

Dear Sir/Madam,

 

Subject: Participation in CPhI-Tokyo, 22-24 April, 2015 and Participation in BSM in Osaka on 20th April 2015

 

 

You are kindly aware that since the launch of Brand India Pharma in 2012 in CPhI-Tokyo, Pharmexcil has been striving to sustain the efforts for greater market access in Japan. Being the second largest pharmaceutical market in the world, Japan looks forward to generics to account for 30% market share in order to reduce the healthcare cost. 

 

Further, it would be important to note that India and Japan has signed CEPA agreement which provides an excellent opportunity for Indian pharmaceuticals manufacturers and exporters to explore opportunities in Japanese market.

 

In order to live up to the challenges of increasing market share in Japan and emerge as reliable partner to provide quality generics to Japan, Pharmexcil with the support of Ministry of Commerce has developed a roadmap to engage with stakeholders in Japan.

 

The key objectives are:

 

  • To raise the awareness of Indian Pharma success story 
  • To create awareness that Indian generics/APIs/Herbal extracts etc. are  bonafide medicines of standard quality
  • To improve the credibility of Indian Pharma industry
  • To position India as global pharmacy of world and stands for Responsible healthcare
  • To make India as HUB for manufacture of pharmaceuticals with cost reduction benefits

 

In this direction, Pharmexcil had already initiated necessary actions which include:

 

  • B2B meeting with Pharma manufacturers /stake holders in collaboration with Osaka pharmaceutical Manufacturers' Association (OPMA) at Osaka, on 20th April 2015.
  • Participation in CPhI-Tokyo(22-24th April 2015) at Big Sight Tokyo
  • Seminar titled "India -Japan Pharma Summit" on 22nd April in Tokyo on the sidelines of Exhibition
  • Sponsoring Cocktail evening organized by UBM for networking opportunities on 22nd April 2015

 

Members are requested to participate in B2B meeting in Osaka and expo at Tokyo.  Japan has lots of opportunities for contract manufacturing. This would be one way of market entry to Japan. About 25 members have already confirmed participation in the B2B at Osaka.

 

Members are requested to take up the stalls in India Pavilion (135 sqm). The stalls available in India Pavilion will be of 9 sqm and in multiples. The made up stall cost would be Rs. 350000/- for 9 sqm.  Please note that the cost towards the stall is highly subsidized.

 

Some common space will be provided in the Council's stand. The cost of this facility is Rs. 200000/- The number of participants in common space is limited to five only.

 

Members may also avail MDA reimbursement of upto Rs.150000/- as per MDA guidelines.

 

Please confirm your participation by 10th March 2015 through e-mail at rodelhi@pharmexcil.com indicating the size of the stall. Confirmation of stall allotment will be given only after receipt of payment. Stall allotment is based on first come-first serve basis and only on receipt of payment. The layout is on the website as well for reference.

 

We once again request you to consider participating in this unique fair which gives excellent opportunity for entering Japanese markets.

 

Looking forward to your confirmation

 

With best regards

 

Dr P V Appaji

Director General

H.O.: 101, Aditya Trade Centre, Ameerpet, Hyderbad-500038
Tel: +91-40-23735462/66, Fax: +91-40-23735464
Email: info@pharmexcil.com Website: www.pharmexcil.com